Stereotaxis Reports Q3 2025 Revenue of $7.5M, Net Loss $6.5M; Guides Q4 Revenue Above $9M

Stereotaxis, Inc.

2025-Q3 EPS reported -$0.19 vs consensus -$0.06 ▼ miss (-210.5%)

Q3 2025 revenue totaled $7.5M, with system revenue of $1.9M and recurring revenue of $5.6M.
Net loss was $6.5M; adjusted net loss excluding non-cash charges was $2.4M.
Cash and equivalents were $10.5M with no debt; additional $4M expected from July financing.
FDA clearance for GenesisX robotic system announced; MAGiC Sweep generated over $300k in first two months.
Q4 2025 revenue expected to exceed $9M, supporting annual revenue growth of over 20%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.